A phase II study of oral etoposide in elderly patients with small cell lung cancer.

Thirty five previously untreated patients with small cell lung cancer older than 70 years were treated with oral etoposide (800 mg/m2 over five consecutive days) every four weeks. Twenty two patients had extensive disease and 13 limited disease. The overall response rate was 71%. The median survival...

Full description

Saved in:
Bibliographic Details
Main Authors: Smit, E F, Carney, D N, Harford, P, Sleijfer, D T, Postmus, P E
Format: Artigo
Language:Inglês
Published: 1989
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC461991/
https://ncbi.nlm.nih.gov/pubmed/2477908
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items